Patient Identification, Surgical Applications

Any new solutions in structural heart disease using pMCS?

Presented by Dr. Bastian Schmack

EACTS 2021

PD Schmack (Essen, Germany) explained that Impella can also give support in other indications than CS, e.g. in structural heart disease of mitral regurgitation, due to the overestimation of LV function. He summarized that the perioperative low output syndrome causes severe limitation in outcome of MV surgery and severe HFrEF. pMCS in structural heart disease might be an additional tool in severe LV dysfunction to overcome initial decrease in function.


View All Posts

Sign up for latest updates

NPS - 624